1. 81P Efficacy of weekly paclitaxel-bevacizumab combination in advanced non squamous non-small cell lung cancer (NSCLC) progressing after immune checkpoint inhibitors - AVATAX, a retrospective multicentric study: Preliminary data. (15th December 2019) Authors: Valery, S C; Chouaid, C; Rousseau-Bussac, G; Monnet, I; Bilger, G; Boré, P; Pinsolle, J; Descourt, R; Geier, M; Toffart, A C; Cony-Makhoul, P; Robinet, G; Ennahdi, F; Zaccaria, I; Decroisette, C Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗